Company
R&D
Product
Investors
Sustainability
Media
Careers
EN
DW WAY
History
Global Network
Affiliated Companies
Contact Point
R&D Centers
R&D Projects
Achievements
Biologics
Chemicals
CTD LIST
IR Highlights
Financial Info
Stock Info
IR
Sustainability Report
Compliance Program
Corporate Governance
News
Brand Resource
Company
DW WAY
History
Global Network
Affiliated Companies
Contact Point
R&D
R&D Centers
R&D Projects
Achievements
Research Performance
Platform Technology
Product
Biologics
Chemicals
CTD LIST
Investors
IR Highlights
Financial Info
Stock Info
IR
Sustainability
Sustainability Report
Compliance Program
Corporate Governance
Overview
Board Directors
Stockholder Info
Media
News
Brand Resource
Careers
Daewoong Pharmaceutical Presents Phase 3 Clinical Trial Results of New Diabetes Treatment ‘Enavogliflozin’ and Roadmap to Enter 50 Countries by 2030
